Terns Pharmaceuticals, Inc. TERN

Full chart Compare
Set alert

Price alert · TERN

All alert types
52.95 USD 0.00 (+0.00%)

At closeMay 15, 2026, 4:00 PM EDT

52.97 +0.02 +0.04%

After hours · May 15, 4:00 PM ET

52.95 Day range 52.97
12.77 52-week range 53.19
YTD
+31.06%
1 year
+1,797.85%

Revenue & Expenses

Other Income → Expenses: $210.00KExpenses → Selling, General & Admin: $19.55MExpenses → Research & Development: $31.31MExpenses → Income Tax: $508.00KGross Profit → Expenses: $1.00MRevenue → Gross Profit: $1.00MNet Loss → Expenses: $50.16MOther Income$210.00KGross Profit$1.00MNet Loss$50.16MExpenses$51.37MSelling, General & Admin$19.55MResearch & Development$31.31MIncome Tax$508.00KRevenue$1.00M

Latest period ending Dec 31, 2025 · select a line to chart its full history

TERN annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-110.12M-101.87M-102.56M-62.03M-49.86M
-96.21M-88.85M-90.21M-60.34M-50.16M
-1.03-1.12-1.27-1.67-2.21
TERN annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
524.75M161.44M79.93M143.24M47.70M
1.03B363.93M268.52M287.03M168.07M
18.55M18.06M13.15M10.08M7.77M
919.00K1.35M603.00K1.21M0
1.01B345.87M255.37M276.94M160.30M
TERN annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-82.18M-70.02M-67.39M-49.11M-41.83M
-298.04M-12.41M-37.99M-22.27M-119.70M
743.51M164.00M41.95M167.09M134.39M
363.31M81.51M-63.31M95.54M-27.16M